Table 1 Baseline patient characteristics

Age, mean (SD)

66 (11.6)

Gender, n (%)

 Female

9 (36%)

 Male

16 (64%)

ECOG performance status, n (%)

 0

10 (40%)

 1

15 (60%)

 2 + 

0 (0%)

Lesion type, n (%)

 Primary NSCLC

2 (8%)

 Locally recurrent

1 (4%)

 Metastasis

22 (88%)

Histology, n (%)

 Renal cell carcinoma

6 (24%)

 NSCLC

5 (20%)

 Soft tissue sarcoma

5 (20%)

 Gynecological

2 (8%)

 Hepatocellular carcinoma

2 (8%)

 Other^a

5 (20%)

 CTV volume (cc), mean (SD)

11.6 (12.4)

Lesion location^b, n (%)

 Ultra-central

20 (54.1%)

 Parenchymal target

13 (65%)

 Hilar/nodal target

7 (35%)

 Central

9 (24.3%)

 Peripheral

8 (21.6%)

Prior therapy for different lung tumors, n (%)

 Systemic therapy

18 (72%)

 Lung radiation (EBRT or brachytherapy)

14 (56%)

 Minimally invasive procedure

8 (32%)

 None

2 (8%)